Azwidihwi Takalani

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

Ameena Goga, Linda‐Gail Bekker, Nigel Garrett et al. · The Lancet · 2022 · 49 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study

Glenda Gray, Shirley Collie, Nigel Garrett et al. · medRxiv · 2021 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

Glenda Gray, Kathryn Mngadi, Ludo Lavreys et al. · The Lancet Infectious Diseases · 2024 · 40 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa

Ameena Goga, Linda‐Gail Bekker, Nigel Garrett et al. · medRxiv · 2021 · 26 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +11

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

Simbarashe Takuva, Azwidihwi Takalani, Ishen Seocharan et al. · PLoS Medicine · 2022 · 21 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17